Topically Applied Hsp90 Inhibitor 17AAG Inhibits UVR-Induced Cutaneous Squamous Cell Carcinomas

Journal of Investigative Dermatology

Volumn 135, Issue 4, 2015, Pages 1098-1107

  Singh, Anupama ^a   Singh, Ashok ^a   Sand, Jordan M ^a   Bauer, Samuel J ^a   Bin Hafeez, Bilal ^a   Meske, Louise ^a   Verma, Ajit K ^a  

^a University of Wisconsin Health   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETONE; COLLAGEN TYPE 4; DIMETHYL SULFOXIDE; GELATINASE A; GELATINASE B; HEAT SHOCK PROTEIN 90; HEAT SHOCK PROTEIN 90 BETA; PROTEIN KINASE B; PROTEIN KINASE C EPSILON; SERINE; STAT3 PROTEIN; TANESPIMYCIN; TYROSINE; UNCLASSIFIED DRUG; BENZOQUINONE DERIVATIVE; HSP90B1 PROTEIN, MOUSE; MACROCYCLIC LACTAM; MATRIX METALLOPROTEINASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANCER INHIBITION; CANCER PREVENTION; DRUG DISTRIBUTION; EPIDERMIS; EPIDERMIS HYPERPLASIA; FVB MOUSE; HAIRLESS MOUSE; HYPERPLASIA; INCIDENCE; INFLAMMATION; KERATINOCYTE; MOUSE; NONHUMAN; ORGAN TRANSPLANTATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN INTERACTION; RADIATION EXPOSURE; SERUM; SKH 1 MOUSE; SKIN CARCINOMA; SKIN HYPERPLASIA; SKIN PROTECTION; TRANSGENIC MOUSE; ULTRAVIOLET A RADIATION; ULTRAVIOLET B RADIATION; ULTRAVIOLET RADIATION; WILD TYPE; WRINKLE; ANIMAL; ANTAGONISTS AND INHIBITORS; CHEMISTRY; DRUG EFFECTS; HUMAN; MELANOMA; METABOLISM; NEOPLASMS, RADIATION-INDUCED; SKIN; SKIN NEOPLASMS;

ACETONE; ANIMALS; BENZOQUINONES; DIMETHYL SULFOXIDE; EPIDERMIS; HSP90 HEAT-SHOCK PROTEINS; HUMANS; INFLAMMATION; LACTAMS, MACROCYCLIC; MATRIX METALLOPROTEINASES; MELANOMA; MICE; NEOPLASMS, RADIATION-INDUCED; PROTEIN KINASE C-EPSILON; SKIN; SKIN NEOPLASMS; ULTRAVIOLET RAYS;

EID: 84925367433     PISSN: 0022202X     EISSN: 15231747     Source Type: Journal    
DOI: 10.1038/jid.2014.460     Document Type: Article

References (59)

1. Anonymous Skin Cancer; American Cancer Society (2014) Cancer facts and figures. American Cancer Society: Atlanta
2. Aziz MH, Manoharan HT, Verma AK (2007) Protein kinase C epsilon, which sensitizes skin to sun's UV radiation-induced cutaneous damage and development of squamous cell carcinomas, associates with Stat3. Cancer Res 67:1385-94
3. Bagatell R, Gore L, Egorin MJ et al. (2007) Phase I pharmacokinetic and pharmacodynamic study of 17-N-allylamino-17-demethoxygeldanamycin in pediatric patients with recurrent or refractory solid tumors: a pediatric oncology experimental therapeutics investigators consortium study. Clin Cancer Res 13:1783-8
4. Bangash HK, Colegio OR (2012) Management of non-melanoma skin cancer in immunocompromised solid organ transplant recipients. Curr Treat Options Oncol 13:354-76
5. Bath-Hextall F, Leonardi-Bee J, Somchand N et al. (2007) Interventions for preventing non-melanoma skin cancers in high-risk groups. Cochrane Database Syst Rev 17:CD005414
6. Berton TR, Mitchell DL, Fischer SM et al. (1997) Epidermal proliferation but not quantity of DNA photodamage is correlated with UV-induced mouse skin carcinogenesis. J Invest Dermatol 109:340-7
7. Biamonte MA, Van de Water R, Arndt JW et al. (2010) Heat shock protein 90: inhibitors in clinical trials. J Med Chem 53:3-17
8. Bracher A, Hartl FU (2006) Hsp90 structure: when two ends meet. Nat Struct Mol Biol 13:478-80
9. de Gruijl FR, van Kranen HJ, Mullenders LH (2001) UV-induced DNA damage, repair, mutations and oncogenic pathways in skin cancer. J Photochem Photobiol B 63:19-27
10. Den RB, Lu B (2012) Heat shock protein 90 inhibition: rationale and clinical potential. Ther Adv Med Oncol 4:211-8
11. Egorin MJ, Zuhowski EG, Rosen DM et al. (2001) Plasma pharmacokinetics and tissue distribution of 17-(allylamino)-17-demethoxygeldanamycin (NSC 330507) in CD2F1 mice1. Cancer Chemother Pharmacol 47:291-302
12. Enk CD, Sredni D, Blauvelt A et al. (1995) Induction of IL-10 gene expression in human keratinocytes by UVB exposure in vivo and in vitro. J Immunol 154:4851-6
13. Fisher GJ, Datta SC, Talwar HS et al. (1996) Molecular basis of sun-induced premature skin ageing and retinoid antagonism. Nature 379:335-9
14. Gartner EM, Silverman P, Simon M et al. (2012) A phase II study of 17-allylamino-17-demethoxygeldanamycin in metastatic or locally advanced, unresectable breast cancer. Breast Cancer Res Treat 131:933-7
15. Goetz MP, Toft D, Reid J et al. (2005) Phase I trial of 17-allylamino-17-demethoxygeldanamycin in patients with advanced cancer. J Clin Oncol 23:1078-87
16. Goldman GD (1998) Squamous cell cancer: a practical approach. Semin Cutan Med Surg 17:80-95
17. Gould CM, Kannan N, Taylor SS et al. (2009) The chaperones Hsp90 and Cdc37 mediate the maturation and stabilization of protein kinase C through a conserved PXXP motif in the C-terminal tail. J Biol Chem 284:4921-35
18. Heath EI, Hillman DW, Vaishampayan U et al. (2008) A phase II trial of 17-allylamino-17-demethoxygeldanamycin in patients with hormone-refractory metastatic prostate cancer. Clin Cancer Res 14:7940-6
19. Huang C, Ma Wy, Bowden GT et al. (1996) Ultraviolet B-induced activated protein-1 activation does not require epidermal growth factor receptor but is blocked by a dominant negative PKClambda/iota. J Biol Chem 271:31262-8
20. Hubbard J, Erlichman C, Toft DO et al. (2011) Phase I study of 17-allylamino-17 demethoxygeldanamycin, gemcitabine and/or cisplatin in patients with refractory solid tumors. Invest New Drugs 29:473-80
21. Imokawa G (2009) Mechanism of UVB-induced wrinkling of the skin: paracrine cytokine linkage between keratinocytes and fibroblasts leading to the stimulation of elastase. J Investig Dermatol Symp Proc 14:36-43
22. Inomata S, Matsunaga Y, Amano S et al. (2003) Possible involvement of gelatinases in basement membrane damage and wrinkle formation in chronically ultraviolet B-exposed hairless mouse. J Invest Dermatol 120:128-34
23. Isoherranen K, Punnonen K, Jansen C et al. (1999) Ultraviolet irradiation induces cyclooxygenase-2 expression in keratinocytes. Br J Dermatol 1999 140:1017-22
24. Jansen AP, Dreckschmidt NE, Verwiebe EG et al. (2001a) Relation of the induction of epidermal ornithine decarboxylase and hyperplasia to the different skin tumor-promotion susceptibilities of protein kinase C alpha, - delta and -epsilon transgenic mice. Int J Cancer 93:635-43
25. Jansen AP, Verwiebe EG, Dreckschmidt NE et al. (2001b) Protein kinase C-epsilon transgenic mice: a unique model for metastatic squamous cell carcinoma. Cancer Res 61:808-12
26. Jung SK, Lee KW, Kim HY et al. (2010) Myricetin suppresses UVB-induced wrinkle formation and MMP-9 expression by inhibiting Raf. Biochem Pharmacol 79:1455-61
27. Kazanietz MG (2000) Eyes wide shut: protein kinase C isozymes are not the only receptors for the phorbol eopster tumor promoters. Mol Carcinog 28:5-11
28. Lindelöf B, Sigurgeirsson B, Gäbel H et al. (2000) Incidence of skin cancer in 5356 patients following organ transplantation. Br J Dermatol 143:513-9
29. Matsuda M, Hoshino T, Yamakawa N et al. (2013) Suppression of UV-induced wrinkle formation by induction of HSP70 expression in mice. J Invest Dermatol 133:919-28
30. Miyata Y, Nakamoto H, Neckers L et al. (2013) The therapeutic target hsp90 and cancer hallmarks. Curr Pharm Des 19:347-65
31. Neckers L (2002) Hsp90 inhibitors as novel cancer chemotherapeutic agents. Trends Mol Med 8:S55-61
32. Neckers L (2006) Chaperoning oncogenes: Hsp90 as a target of geldanamycin. Handb Exp Pharmacol 172:259-77
33. Pacey S, Gore M, Chao D et al. (2012) A Phase II trial of 17-allylamino, 17-demethoxygeldanamycin (17-AAG, tanespimycin) in patients with metastatic melanoma. Invest New Drugs 30:341-9
34. Rabe JH, Mamelak AJ, McElgunn PJ et al. (2006) Photoaging: mechanisms and repair. J Am Acad Dermatol 55:1-19
35. Ramsay HM, Reece SM, Fryer AA et al. (2007) Seven-year prospective study of nonmelanoma skin cancer incidence in UK renal transplant recipients. Transplantation 84:437-9
36. Reddig PJ, Dreckschmidt NE, Zou J et al. (2000) Transgenic mice overexpressing protein kinase C epsilon in their epidermis exhibit reduced papilloma burden but enhanced carcinoma formation after tumor promotion. Cancer Res 60:595-602
37. Rosen CF, Gajic D, Drucker DJ et al. (1990) Ultraviolet radiation induction of ornithine decarboxylase in rat keratinocytes. Cancer Res 50:2631-5
38. Saif MW, Erlichman C, Dragovich T et al. (2013) Open-label, dose-escalation, safety, pharmacokinetic, and pharmacodynamic study of intravenously administered CNF1010 (17-(allylamino)-17-demethoxygeldanamycin [17-AAG]) in patients with solid tumors. Cancer Chemother Pharmacol 71:1345-55
39. Sand JM, Aziz MH, Dreckschmidt NE et al. (2010) PKCepsilon overexpression, irrespective of genetic background, sensitizes skin to UVR-induced development of squamous-cell carcinomas. J Invest Dermatol 130:270-7
40. Sand JM, Hafeez BB, Aziz MH et al. (2012) Ultraviolet radiation and 12-O-tetradecanoylphorbol-13-acetate-induced interaction of mouse epidermal protein kinase C e with Stat3 involve integration with Erk1/2. Mol Carcinog 51:291-302
41. Scaltriti M, Dawood S, Cortes J (2012) Molecular pathways: targeting hsp90 - who benefits and who does not. Clin Cancer Res 18:4508-13
42. Shin HC, Cho H, Lai TC (2012) Pharmacokinetic study of 3-in-1 poly(ethylene glycol)-block-poly(D,L-lactic acid) micelles carrying paclitaxel, 17-allylamino-17-demethoxygeldanamycin and rapamycin. J Control Release 163:93-9
43. Shin MH, Seo JE, Kim YK et al. (2012) Chronic heat treatment causes skin wrinkle formation and oxidative damage in hairless mice. Mech Ageing Dev 133:92-8
44. Solit DB, Osman I, Polsky D et al. (2008) Phase II trial of 17-allylamino-17-demethoxygeldanamycin in patients with metastatic melanoma. Clin Cancer Res 14:8302-7
45. Sõti C, Nagy E, Giricz Z et al. (2005) Heat shock proteins as emerging therapeutic targets. Br J Pharmacol 146:769-80
46. Sreedhar AS, Kalmár E, Csermely P et al. (2004) Hsp90 isoforms: functions, expression and clinical importance. FEBS Lett 562:11-5
47. Stebbins CE, Russo AA, Schneider C et al. (1997) Crystal structure of an Hsp90-geldanamycin complex: targeting of a protein chaperone by an antitumor agent. Cell 89:239-50
48. Taipale M, Krykbaeva I, Koeva M et al. (2012) Quantitative analysis of hsp90-client interactions reveals principles of substrate recognition. Cell 150:987-1001
49. Talwar HS, Griffiths CE, Fisher GJ et al. (1995) Reduced type I and type III procollagens in photodamaged adult human skin. J Invest Dermatol 105:285-90
50. Usmani SZ, Bona R, Li Z (2009) 17AAG for HSP90 inhibition in cancer - from bench to bedside. Curr Mol Med 9:654-64
51. Verma AK, Wheeler DL, Aziz MH et al. (2006) Protein kinase C epsilon and development of squamous cell carcinoma, the nonmelanoma human skin cancer. Mol Carcinog 45:381-8
52. Weigel BJ, Blaney SM, Reid JM et al. (2007) A phase I study of 17-allylaminogeldanamycin in relapsed/refractory pediatric patients with solid tumors: a Children's Oncology Group study. Clin Cancer Res 13:1789-93
53. Wheeler DL, Li Y, Verma AK (2005) Protein kinase C epsilon signals ultraviolet light-induced cutaneous damage and development of squamous cell carcinoma possibly through Induction of specific cytokines in a paracrine mechanism. Photochem Photobiol 81:9-18
54. Wheeler DL, Martin KE, Ness KJ et al. (2004) Protein kinase C epsilon is an endogenous photosensitizer that enhances ultraviolet radiation-induced cutaneous damage and development of squamous cell carcinomas. Cancer Res 64:7756-65
55. Wheeler DL, Ness KJ, Oberley TD et al. (2003) Protein kinase Cepsilon is linked to 12-O-tetradecanoylphorbol-13-acetate-induced tumor necrosis factor-alpha ectodomain shedding and the development of metastatic squamous cell carcinoma in protein kinase C epsilon transgenic mice. Cancer Res 63:6547-55
56. Whitesell L, Santagata S, Lin NU (2012) Inhibiting HSP90 to treat cancer: a strategy in evolution. Curr Mol Med 12:1108-24
57. Ziegler A, Jonason AS, Leffell DJ et al. (1994) Sunburn and p53 in the onset of skin cancer. Nature 372:773-6
58. Zhang Y, Liu G, Dong Z (2001) MSK1 and JNKs mediate phosphorylation of STAT3 in UVA-irradiated mouse epidermal JB6 cells. J Biol Chem 276:42534-42
59. Zuehlke A, Johnson JL (2010) Hsp90 and co-chaperones twist the functions of diverse client proteins. Biopolymers 93:211-7